Focusing On Fluoride: From FDA To Class Action

On June 16, as a follow-up to its May 13 announcement that it intends to begin the process to remove ingestible fluoride prescription drug products for children from the market, the…

Original article online at: https://www.law360.com/healthcare-authority/articles/2357093/focusing-on-fluoride-from-fda-to-class-action